MMP-13 inhibitors (Roche)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMMP-13 inhibitors (Roche)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 13 inhibitors
TargetsMatrix metalloproteinase 13
Therapy Area/IndicationsInflammationOsteoarthritisArthritis, Rheumatoid +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Palo Alto Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Palo Alto Llc
Active IndicationsN/A
Inactive IndicationsInflammationOsteoarthritisArthritis, Rheumatoid +[5] 

Other Information

ATC CodeN/A
Related LinksN/A